Filing Details
- Accession Number:
- 0001179110-21-010721
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-09 16:01:49
- Reporting Period:
- 2021-12-07
- Accepted Time:
- 2021-12-09 16:01:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1597264 | Blueprint Medicines Corp | BPMC | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1683600 | L Tracey Mccain | C/O Blueprint Medicines Corporation 45 Sidney Street Cambridge MA 02139 | Evp And Chief Legal Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-12-07 | 5,000 | $28.36 | 38,441 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-12-07 | 4,328 | $97.46 | 34,113 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-12-07 | 572 | $96.38 | 33,541 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-12-07 | 100 | $95.54 | 33,441 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2021-12-07 | 5,000 | $0.00 | 5,000 | $28.36 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 55,000 | 2026-10-03 | No | 4 | M | Direct |
Footnotes
- Effected pursuant to a trading plan adopted on February 22, 2021 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- Includes 167 shares that were previously acquired under the Issuer's employee stock purchase plan.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.97 to $97.91 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.87 to $96.73 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
- This option was granted on October 3, 2016 and fully vested as of the date hereof.
Billionaire Hedge Funds
